The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib/II open-label, randomized evaluation of 2L atezolizumab (atezo) + PEGPH20 versus control in MORPHEUS-pancreatic ductal adenocarcinoma (M-PDAC) and MORPHEUS-gastric cancer (M-GC).
 
Andrew H. Ko
Honoraria - Clinical Care Options; Dava Oncology; Elsevier; OncLive; PER; Pharmatecture; PlatformQ Health; Research to Practice; Xcenda
Consulting or Advisory Role - ERYTECH Pharma; Gilead Sciences; Gritstone Bio; Imugene; MORE Health; SynCoreBio
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst)
 
Jeeyun Lee
Consulting or Advisory Role - Oncologie; Seagen
Research Funding - AstraZeneca; Lilly; Merck Sharp & Dohme
 
MARIA ALSINA
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD Oncology; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; MSD; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Roche/Genentech
 
Jaffer A. Ajani
Honoraria - Acrotech Biopharma; Aduro Biotech; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAVA Pharmaceuticals; Lilly; Merck; zymeworks
Consulting or Advisory Role - American Cancer Society; BeiGene; Bristol-Myers Squibb; Insys Therapeutics; Merck; Vaccinogen
Research Funding - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Delta-Fly Pharma; Gilead Sciences; Lilly/ImClone; Merck; Novartis; ProLynx; Roche/Genentech; Taiho Pharmaceutical; Takeda; Zymeworks
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly
 
Yung-Jue Bang
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; Genexine; GlaxoSmithKline; Green Cross; Hanmi; Lilly; Merck Serono; MSD Oncology; Novartis; Samyang; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Chong Kun Dang Pharmaceutical (Inst); Curis (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Genexine (Inst); GlaxoSmithKline (Inst); Green Cross (Inst); Lilly (Inst); Macrogenics (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Hyun Cheol Chung
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Celltrion; Gloria Biosciences; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono
Research Funding - Amgen; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical
 
Jill Lacy
Consulting or Advisory Role - AstraZeneca; Celgene; Ipsen; KeyQuest Health; KeyQuest Health; Merck; Navigant Consulting; Sirtex Medical
Travel, Accommodations, Expenses - Lilly
 
Charles D. Lopez
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Boston Scientific; Celgene; Exelixis; Pfizer
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - RenovoRx
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Bayer; Celgene; Genentech; Halozyme; Merck Serono; Novartis; Roche; Taiho Pharmaceutical; Zymeworks
Research Funding - Array BioPharma; AstraZeneca; Lilly
 
Eileen Mary O'Reilly
Consulting or Advisory Role - Agios (I); AstraZeneca (I); Bayer (I); BeiGene (I); Berry Genomics (I); Celgene (I); CytomX Therapeutics; Debiopharm Group (I); Debiopharm Group (I); Eisai (I); Exelixis/Ipsen (I); Flatiron Health (I); Genentech/Roche (I); Genoscience Pharma (I); Incyte (I); Janssen; LAM Therapeutics (I); Lilly (I); Loxo; Merck; Minapharma (I); QED Therapeutics (I); RedHill Biopharma (I); Sillajen (I); SOBI; Targovax; Yiviva (I)
Research Funding - AstraZeneca/MedImmune (Inst)
 
Jens T Siveke
Stock and Other Ownership Interests - FAPI Holding
Consulting or Advisory Role - AstraZeneca (Inst); Celgene
Research Funding - Bristol-Myers Squibb; Celgene
Travel, Accommodations, Expenses - AstraZeneca (Inst); Bristol-Myers Squibb; Celgene; Roche; SERVIER (Inst)
 
Simon Allen
Employment - Genentech
 
Nedal Jaffer Abdulla Al-Sakaff
Employment - Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Hila Barak
Employment - Baxalta; Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Baxalta; Genentech/Roche
 
Janet Lau
Employment - Genentech
 
Shi Li
Employment - Genentech
 
Anne-Cecile Retiere
Employment - Roche
 
Colby Shemesh
Employment - Genentech
 
Xiaosong Zhang
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Patents in cancer genomics
Travel, Accommodations, Expenses - Genentech/Roche
 
Kyu-Pyo Kim
Travel, Accommodations, Expenses - Agios; Roche/Genentech; Roche/Genentech